Global
# |
Name |
Return on Capital Employed (ROCE) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
10,737.55%
|
March 31, 2024 | USD 0.16 | 1.37% |
|
India |
|
2 |
2,404.33%
|
Dec. 31, 2023 | USD 1.53 | -6.13% |
|
United Kingdom |
|
3 |
1,869.76%
|
Dec. 31, 2023 | USD 3.15 | -5.12% |
|
Canada |
|
4 |
1,410.79%
|
Sept. 30, 2024 | USD 12.31 | -23.96% |
|
United States |
|
5 |
1,328.91%
|
June 30, 2024 | USD 0.89 | -3.59% |
|
United States |
|
6 |
639.13%
|
Dec. 31, 2023 | USD 5.51 | -1.08% |
|
Israel |
|
7 |
555.22%
|
Sept. 30, 2024 | USD 6.52 | -5.10% |
|
United States |
|
8 |
500.73%
|
March 31, 2024 | USD 1.01 | -5.61% |
|
United States |
|
9 |
389.57%
|
Dec. 31, 2023 | USD 9.91 | -0.63% |
|
Italy |
|
10 |
314.93%
|
Dec. 31, 2023 | USD 2.81 | 6.87% |
|
Belgium |
|
11 |
301.99%
|
Sept. 30, 2024 | USD 1.17 | 2.63% |
|
United States |
|
12 |
282.00%
|
Sept. 30, 2024 | USD 2.52 | -0.79% |
|
United States |
|
13 |
159.55%
|
Dec. 31, 2023 | USD 0.05 | 1.50% |
|
United Kingdom |
|
14 |
157.54%
|
Dec. 31, 2023 | USD 1.01 | 1.23% |
|
Poland |
|
15 |
116.56%
|
Dec. 31, 2023 | USD 14.50 | 8.00% |
|
Switzerland |
|
16 |
91.27%
|
March 31, 2024 | USD 31.35 | -1.26% |
|
India |
|
17 |
79.66%
|
Dec. 31, 2023 | USD 64.30 | -0.35% |
|
India |
|
18 |
71.75%
|
Dec. 31, 2023 | USD 81.56 | -2.90% |
|
Denmark |
|
19 |
67.63%
|
Dec. 31, 2023 | USD 3.33 | 0.41% |
|
Sweden |
|
20 |
66.72%
|
March 31, 2024 | USD 1.16 | -0.19% |
|
India |
|
21 |
66.09%
|
March 31, 2024 | USD 2.75 | 4.60% |
|
India |
|
22 |
61.65%
|
March 31, 2024 | USD 10.94 | 1.86% |
|
United Kingdom |
|
23 |
60.55%
|
Dec. 31, 2023 | USD 0.44 | -0.60% |
|
Hong Kong |
|
24 |
58.64%
|
Sept. 30, 2024 | USD 6.33 | 4.46% |
|
United States |
|
25 |
58.42%
|
Sept. 30, 2024 | USD 7.37 | 0.96% |
|
United States |
|
26 |
56.02%
|
March 31, 2024 | USD 0.27 | 0.92% |
|
Hong Kong |
|
27 |
51.61%
|
Dec. 31, 2023 | USD 11.90 | 21.74% |
|
South Korea |
|
28 |
50.37%
|
June 30, 2024 | USD 157.25 | 0.24% |
|
Australia |
|
29 |
50.21%
|
March 31, 2024 | USD 7.47 | -1.19% |
|
Japan |
|
30 |
48.66%
|
June 30, 2024 | USD 61.83 | 3.06% |
|
India |
|
31 |
48.29%
|
Sept. 30, 2024 | USD 418.63 | -0.94% |
|
United States |
|
32 |
46.92%
|
Sept. 30, 2024 | USD 330.91 | -5.99% |
|
United States |
|
33 |
46.73%
|
March 31, 2024 | USD 3.29 | -0.45% |
|
Malaysia |
|
34 |
45.10%
|
Sept. 30, 2024 | USD 50.91 | 0.74% |
|
Poland |
|
35 |
43.43%
|
Dec. 31, 2023 | USD 1.76 | 1.20% |
|
Spain |
|
36 |
42.24%
|
March 31, 2024 | USD 326.23 | -0.98% |
|
India |
|
37 |
41.12%
|
Sept. 30, 2024 | USD 87.67 | 0.65% |
|
United States |
|
38 |
40.25%
|
March 31, 2024 | USD 23.94 | -0.87% |
|
India |
|
39 |
39.99%
|
Dec. 31, 2023 | USD 2.71 | -1.34% |
|
Japan |
|
40 |
39.61%
|
Dec. 31, 2023 | USD 4.82 | -5.87% |
|
Japan |
|
41 |
39.39%
|
Dec. 31, 2023 | USD 10.87 | -0.41% |
|
Turkey |
|
42 |
39.32%
|
Sept. 30, 2024 | USD 92.62 | -2.15% |
|
United States |
|
43 |
39.28%
|
Dec. 31, 2023 | USD 6.64 | 6.03% |
|
China |
|
44 |
38.86%
|
Sept. 30, 2024 | USD 3.65 | -3.18% |
|
United States |
|
45 |
38.56%
|
March 31, 2024 | USD 8.38 | -2.25% |
|
Japan |
|
46 |
38.01%
|
July 31, 2024 | USD 6.07 | -3.40% |
|
Japan |
|
47 |
37.67%
|
Dec. 31, 2023 | USD 33.70 | 0.30% |
|
Spain |
|
48 |
37.00%
|
Dec. 31, 2023 | USD 2.97 | 0.98% |
|
Sweden |
|
49 |
36.91%
|
Dec. 31, 2023 | USD 59.78 | -0.59% |
|
Spain |
|
50 |
36.66%
|
Sept. 30, 2024 | USD 4.54 | -7.91% |
|
United States |
The Pharmaceuticals company with the highest Return on Capital Employed (ROCE) is TAKE Solutions Limited (NSE: TAKE.NS) at 10,737.55%.
The Pharmaceuticals company with the lowest Return on Capital Employed (ROCE) is Elutia Inc. (NasdaqCM: ELUT) at -3,223.45%.
The top 10 Pharmaceuticals companies the Global by Return on Capital Employed (ROCE) are TAKE Solutions Limited, Akanda Corp., Achieve Life Sciences, Inc., Atara Biotherapeutics, Inc., Calidi Biotherapeutics, Inc., RedHill Biopharma Ltd., Avalo Therapeutics, Inc., Allarity Therapeutics, Inc., Newron Pharmaceuticals S.p.A. and Sequana Medical NV.
The bottom 10 Pharmaceuticals companies by Return on Capital Employed (ROCE) are Elutia Inc., Ji Yao Holding Group Co., Ltd., Clearmind Medicine Inc., NFL Biosciences SA, Kaya Limited, Daré Bioscience, Inc., 180 Life Sciences Corp., Agenus Inc., Palatin Technologies, Inc. and Hunan Jingfeng Pharmaceutical Co.,Ltd..